Global Herceptin Biosimilar Market Growth 2019-2024

20off

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.

According to this study, over the next five years the Herceptin Biosimilar market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Herceptin Biosimilar business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Herceptin Biosimilar market by product type, application, key manufacturers and key regions and countries.

This study considers the Herceptin Biosimilar value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinics
Oncology Centers
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Herceptin Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Herceptin Biosimilar market by identifying its various subsegments.
Focuses on the key global Herceptin Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Herceptin Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Herceptin Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

3 Reports

USD 8,250
  • PDF
  • EXCEL DATA (NO)
  • PPT (NO)
  • HARD COPY (NO)
  • 15% FREE CUSTOMISATION
  • 5 USERS
  • 3 ANALYST CALL
  • Add to cart

6 Reports

USD 15,000
  • PDF
  • EXCEL DATA
  • PPT (NO)
  • HARD COPY (NO)
  • 20% FREE CUSTOMISATION
  • 10 USERS
  • 12 ANALYST CALL
  • Add to cart

9 Reports

USD 20,250
  • PDF
  • EXCEL DATA
  • PPT
  • HARD COPY (NO)
  • 25% FREE CUSTOMISATION
  • 20 USERS
  • 22 ANALYST CALL
  • Add to cart

12 Reports

USD 24,000
  • PDF
  • EXCEL DATA
  • PPT
  • HARD COPY (NO)
  • 30% FREE CUSTOMISATION
  • UNLIMITED
  • 36 ANALYST CALL
  • Add to cart

Table of Contents

2019-2024 Global Herceptin Biosimilar Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herceptin Biosimilar Consumption 2014-2024
2.1.2 Herceptin Biosimilar Consumption CAGR by Region
2.2 Herceptin Biosimilar Segment by Type
2.2.1 Breast Cancer
2.2.2 Colorectal Cancer
2.2.3 Leukemia
2.2.4 Lymphoma
2.2.5 Other
2.3 Herceptin Biosimilar Consumption by Type
2.3.1 Global Herceptin Biosimilar Consumption Market Share by Type (2014-2019)
2.3.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2014-2019)
2.3.3 Global Herceptin Biosimilar Sale Price by Type (2014-2019)
2.4 Herceptin Biosimilar Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Oncology Centers
2.4.3 Other
2.5 Herceptin Biosimilar Consumption by Application
2.5.1 Global Herceptin Biosimilar Consumption Market Share by Application (2014-2019)
2.5.2 Global Herceptin Biosimilar Value and Market Share by Application (2014-2019)
2.5.3 Global Herceptin Biosimilar Sale Price by Application (2014-2019)

3 Global Herceptin Biosimilar by Manufacturers
3.1 Global Herceptin Biosimilar Sales Market Share by Manufacturers
3.1.1 Global Herceptin Biosimilar Sales by Manufacturers (2017-2019)
3.1.2 Global Herceptin Biosimilar Sales Market Share by Manufacturers (2017-2019)
3.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers
3.2.1 Global Herceptin Biosimilar Revenue by Manufacturers (2017-2019)
3.2.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Herceptin Biosimilar Sale Price by Manufacturers
3.4 Global Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Herceptin Biosimilar Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Herceptin Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Herceptin Biosimilar by Regions
4.1 Herceptin Biosimilar by Regions
4.1.1 Global Herceptin Biosimilar Consumption by Regions
4.1.2 Global Herceptin Biosimilar Value by Regions
4.2 Americas Herceptin Biosimilar Consumption Growth
4.3 APAC Herceptin Biosimilar Consumption Growth
4.4 Europe Herceptin Biosimilar Consumption Growth
4.5 Middle East & Africa Herceptin Biosimilar Consumption Growth

5 Americas
5.1 Americas Herceptin Biosimilar Consumption by Countries
5.1.1 Americas Herceptin Biosimilar Consumption by Countries (2014-2019)
5.1.2 Americas Herceptin Biosimilar Value by Countries (2014-2019)
5.2 Americas Herceptin Biosimilar Consumption by Type
5.3 Americas Herceptin Biosimilar Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Herceptin Biosimilar Consumption by Countries
6.1.1 APAC Herceptin Biosimilar Consumption by Countries (2014-2019)
6.1.2 APAC Herceptin Biosimilar Value by Countries (2014-2019)
6.2 APAC Herceptin Biosimilar Consumption by Type
6.3 APAC Herceptin Biosimilar Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Herceptin Biosimilar by Countries
7.1.1 Europe Herceptin Biosimilar Consumption by Countries (2014-2019)
7.1.2 Europe Herceptin Biosimilar Value by Countries (2014-2019)
7.2 Europe Herceptin Biosimilar Consumption by Type
7.3 Europe Herceptin Biosimilar Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Herceptin Biosimilar by Countries
8.1.1 Middle East & Africa Herceptin Biosimilar Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Herceptin Biosimilar Value by Countries (2014-2019)
8.2 Middle East & Africa Herceptin Biosimilar Consumption by Type
8.3 Middle East & Africa Herceptin Biosimilar Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Herceptin Biosimilar Distributors
10.3 Herceptin Biosimilar Customer

11 Global Herceptin Biosimilar Market Forecast
11.1 Global Herceptin Biosimilar Consumption Forecast (2019-2024)
11.2 Global Herceptin Biosimilar Forecast by Regions
11.2.1 Global Herceptin Biosimilar Forecast by Regions (2019-2024)
11.2.2 Global Herceptin Biosimilar Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Herceptin Biosimilar Forecast by Type
11.8 Global Herceptin Biosimilar Forecast by Application

12 Key Players Analysis
12.1 Amgen
12.1.1 Company Details
12.1.2 Herceptin Biosimilar Product Offered
12.1.3 Amgen Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Amgen News
12.2 AryoGen Biopharma
12.2.1 Company Details
12.2.2 Herceptin Biosimilar Product Offered
12.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 AryoGen Biopharma News
12.3 Biocon
12.3.1 Company Details
12.3.2 Herceptin Biosimilar Product Offered
12.3.3 Biocon Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Biocon News
12.4 Celltrion
12.4.1 Company Details
12.4.2 Herceptin Biosimilar Product Offered
12.4.3 Celltrion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Celltrion News
12.5 Gedeon Richter
12.5.1 Company Details
12.5.2 Herceptin Biosimilar Product Offered
12.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Gedeon Richter News
12.6 Genor Biopharma
12.6.1 Company Details
12.6.2 Herceptin Biosimilar Product Offered
12.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Genor Biopharma News
12.7 Mabion
12.7.1 Company Details
12.7.2 Herceptin Biosimilar Product Offered
12.7.3 Mabion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Mabion News
12.8 Mylan
12.8.1 Company Details
12.8.2 Herceptin Biosimilar Product Offered
12.8.3 Mylan Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Mylan News
12.9 Roche
12.9.1 Company Details
12.9.2 Herceptin Biosimilar Product Offered
12.9.3 Roche Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Roche News
12.10 The Instituto Vital Brazil
12.10.1 Company Details
12.10.2 Herceptin Biosimilar Product Offered
12.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 The Instituto Vital Brazil News

13 Research Findings and Conclusion

Research Process

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistic agencies, and paid databases. This information creates a base for the study. This information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analysed to extract crisp data points which currently affect or are likely to affect the industry over the forecast period. After analysing the information, a proprietary market estimation & forecast technique is applied, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for over the forecast period. After populating the market sizes & estimates, numbers are verified with the industry participants and key opinion leaders. The wide network of industry participants performs a value addition in the research and verify the numbers & estimates of the study. In the last stage of the research process, a final report is prepared which is then published on different websites as well as distributed through various channels. Below figure contains the different stages of the whole research performed to produce the report.

After populating the market sizes & estimates, numbers are verified with the industry participants and key opinion leaders. The wide network of industry participants performs a value addition in the research and verify the numbers & estimates of the study. In the last stage of the research process, a final report is prepared which is then published on different websites as well as distributed through various channels. Below figure contains the different stages of the whole research performed to produce the report.

DATA MINING

Data mining is one of the extensive stages of our research process. It involves the procurement of market data and related information through different verified & credible sources. This step helps to obtain the raw information about the supply chain of the industry, the monetary process of different Products & End-Uses, the pool of market participants & the nature of the industry and the scope of the study. The data mining stage comprises both primary as well as secondary sources of information. Some of the key data sources are as follows:

Secondary Research In the process of secondary research, various sources are referred to identify and collect industry trends and information for the research process. We at having access to some of the most diversified and extensive paid databases which give us the most accurate data/information on markets sizes, Products and pricing.

In the primary research process for data mining, various key industry participants from both supply and demand side are interviewed to obtain both qualitative as well as quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies are conducted to obtain critical qualitative and quantitative aspects pertaining to the market, as well as to assess the prospects for market growth over the forecast period.

ANALYSIS

This step involves the analysis & mapping of all the information procured from the previous step. This step also encompasses the scrutiny of data discrepancies observed across various data sources and finalising the appropriate data for estimation and forecasting. This analysis is done by our experienced panel of industry analysts.

MARKET ESTIMATION

Understanding and penetrating the market in terms of valuation is a crucial task in the process of business research. This again becomes significantly important while investing and choosing the business opportunities. In this regard, we perform two ways market sizing approach simultaneously namely top-down and bottom-up approaches. In this step, we place different data points, numeric attributes, information, and industry trends at an appropriate space in order to deduce the estimates & forecast values over the coming years. We use different mathematical models to estimate the market sizes of different economies and segments. Each of which is further summed up to define the total market. We own a proprietary tool for market estimations which helps us to comprehend market size estimates & forecasts for different markets and industries. Below figure explains the process of market estimation using independent tool employed by our analysts to get the sizing off the market.